Health and medical565441-2026

Netherlands – Devices and instruments for infusion – Marktconsultatie Aferese apparatuur Radboudumc

Radboud Universitair Medisch Centrum/Radboudumc

Buyer country

Netherlands

Publication date

Not specified

Biderra sector

Health and medical

Data source

TED open data

Decision signals

First-pass opportunity review

These signals are calculated from the indexed fields. They help prioritize a review but do not replace eligibility checks in the official procurement documents.

Timing signal
Deadline not indexed

Check the official notice

Indexed data completeness
86%

Based on seven decision fields

Official title coverage
7 languages

Preserved from source-supplied versions

Classification signal
33194100

Medical equipment, pharmaceuticals and personal care products

Official title versions

TED may publish the same notice title in several official languages. Biderra preserves the versions supplied in the source feed.

Spanish

Países Bajos – Instrumentos y aparatos para perfusión – Marktconsultatie Aferese apparatuur Radboudumc

Dutch

Nederland – Apparatuur en instrumentarium voor infuus – Marktconsultatie Aferese apparatuur Radboudumc

Polish

Niderlandy – Urządzenia i przyrządy do infuzji – Marktconsultatie Aferese apparatuur Radboudumc

French

Pays-Bas – Appareils et instruments pour perfusion – Marktconsultatie Aferese apparatuur Radboudumc

German

Niederlande – Ausrüstung und Instrumente für Infusion – Marktconsultatie Aferese apparatuur Radboudumc

Italian

Paesi Bassi – Apparecchi e strumenti per infusione – Marktconsultatie Aferese apparatuur Radboudumc

English

Netherlands – Devices and instruments for infusion – Marktconsultatie Aferese apparatuur Radboudumc

What Biderra adds

For notice 565441-2026, Biderra has normalized the contracting authority country as Netherlands, grouped CPV 33194100 under health and medical, compared the available deadline fields with today, measured field completeness, and preserved 7 source-supplied title versions. The official record remains decisive.